Category: Mesothelioma News
Combination immunotherapy improves survival in mouse models of mesothelioma
Investigators have found that combined treatment with two cancer immunotherapy drugs — one a novel immune modulator and one that focuses and activates the anti-tumor immune response — significantly prolonged survival in mouse models of the aggressive…
Subset of carbon nanotubes poses cancer risk similar to asbestos in mice
Researchers have shown for the first time in mice that long and thin nanomaterials called carbon nanotubes may have the same carcinogenic effect as asbestos: they can induce the formation of mesothelioma. The findings were observed in 10 percent — 25 …
Loose-fill asbestos insulation and health
A landmark study into the health impacts of living in a house with loose-fill asbestos insulation.
Pneumoconiosis: The risk of breathing in dust
Pneumoconiosis is a lung disease caused by dust particles. Symptoms include breathing difficulty and a cough. It can result from exposure to coal dust, asbestos particles, and cotton dust. It is considered an occupational risk. Complications include tu…
Rare genetic cause of peritoneal mesothelioma points to targeted therapy
Mesothelioma is a rare and aggressive tumor that, in many cases, results from exposure to asbestos.
Rare genetic cause of peritoneal mesothelioma points to targeted therapy
Investigators have uncovered a new genetic cause of mesothelioma: a genetic rearrangement in the ALK gene, observed in three patients with peritoneal mesothelioma. Unlike previously known causes, this new discovery points to a potential therapeutic app…
QUIZ: Can We Guess Your Education Level From Your 80s Movie Knowledge?
See if you can identify these classic movies based on a single image!
First immunotherapy for mesothelioma on the horizon, early research suggests
Malignant pleural mesothelioma or MPM is a rare cancer, but its incidence has been rising. This cancer is usually associated with asbestos exposure, and patients have a median life expectancy of only 13-15 months. All patients relapse despite initial c…
Mesothelioma: New trial to fight cancer caused by asbestos
Patients with a hard-to-treat type of cancer are being given new hope in a ground-breaking clinical trial.
Mesothelioma shows promising response to existing immunotherapy drug
Malignant pleural mesothelioma shows a promising response to treatment with the antibody drug pembrolizumab, which is used to treat other cancers.